Resetting of circadian time in peripheral tissues by glucocorticoid signaling
In mammals, circadian oscillators reside not only in the suprachiasmatic nucleus of the brain,
which harbors the central pacemaker, but also in most peripheral tissues. Here, we show …
which harbors the central pacemaker, but also in most peripheral tissues. Here, we show …
[HTML][HTML] A serum shock induces circadian gene expression in mammalian tissue culture cells
A Balsalobre, F Damiola, U Schibler - Cell, 1998 - cell.com
The treatment of cultured rat-1 fibroblasts or H35 hepatoma cells with high concentrations of
serum induces the circadian expression of various genes whose transcription also oscillates …
serum induces the circadian expression of various genes whose transcription also oscillates …
[PDF][PDF] Multiple signaling pathways elicit circadian gene expression in cultured Rat-1 fibroblasts
A Balsalobre, L Marcacci, U Schibler - Current Biology, 2000 - cell.com
In mammals, all overt circadian rhythms are thought to be coordinated by a central pacemaker
residing in the hypothalamic suprachiasmatic nucleus (SCN) [1]. The phase of this …
residing in the hypothalamic suprachiasmatic nucleus (SCN) [1]. The phase of this …
Clock genes in mammalian peripheral tissues
A Balsalobre - Cell and tissue research, 2002 - Springer
For many years, neurons of the suprachiasmatic nucleus (SCN) in the hypothalamus were
thought to contain the unique mammalian clock controlling circadian rhythmicity of peripheral …
thought to contain the unique mammalian clock controlling circadian rhythmicity of peripheral …
[HTML][HTML] The Stat3/GR interaction code: predictive value of direct/indirect DNA recruitment for transcription outcome
D Langlais, C Couture, A Balsalobre, J Drouin - Molecular cell, 2012 - cell.com
Transcription factor recruitment to genomic sites of action is primarily due to direct protein:DNA
interactions. The subsequent recruitment of coregulatory complexes leads to either …
interactions. The subsequent recruitment of coregulatory complexes leads to either …
Pioneer factors as master regulators of the epigenome and cell fate
A Balsalobre, J Drouin - Nature Reviews Molecular Cell Biology, 2022 - nature.com
Pioneer factors are transcription factors with the unique ability to initiate opening of closed
chromatin. The stability of cell identity relies on robust mechanisms that maintain the …
chromatin. The stability of cell identity relies on robust mechanisms that maintain the …
The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodeling
L Budry, A Balsalobre, Y Gauthier… - Genes & …, 2012 - genesdev.cshlp.org
The anterior and intermediate lobes of the pituitary gland derive from the surface ectoderm.
They provide a simple system to assess mechanisms of developmental identity established …
They provide a simple system to assess mechanisms of developmental identity established …
Pioneer factor Pax7 deploys a stable enhancer repertoire for specification of cell fate
…, F Hariri, T Pastinen, Y Gauthier, A Balsalobre… - Nature …, 2018 - nature.com
Pioneer transcription factors establish new cell-fate competence by triggering chromatin
remodeling. However, many features of pioneer action, such as their kinetics and stability, …
remodeling. However, many features of pioneer action, such as their kinetics and stability, …
[HTML][HTML] Pioneer and nonpioneer factor cooperation drives lineage specific chromatin opening
…, J Harris, Y Gauthier, A Bemmo, A Balsalobre… - Nature …, 2019 - nature.com
Pioneer transcription factors are characterized by having the unique property of enabling the
opening of closed chromatin sites, for implementation of cell fates. We previously found that …
opening of closed chromatin sites, for implementation of cell fates. We previously found that …
[HTML][HTML] Mutations in NFKB2and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies
…, JM Capo-Chichi, B Delemer, A Balsalobre… - BMC medical …, 2014 - Springer
Background DAVID syndrome is a rare condition combining anterior pituitary hormone
deficiency with common variable immunodeficiency. NFKB2 mutations have recently been …
deficiency with common variable immunodeficiency. NFKB2 mutations have recently been …